MS Hub Medical Group

Seattle, Washington 98101

0 studies enrolling now · 3 studies all time

What they study most

Multiple Sclerosis, Relapse-Remitting Multiple Sclerosis

Studies at this site

• Study of Oral Fampridine-SR in Multiple Sclerosis — Completed
• A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved Dose — Completed
• Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis — Completed